Literature DB >> 1419640

Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy.

D Murphy1, A T McGown, A Hall, A Cattan, D Crowther, B W Fox.   

Abstract

A study involving the measurement of glutathione S-transferase activities and isoenzyme distributions in human ovarian tumours has been carried out. These tumours have been obtained either at initial debulking surgery, prior to cytotoxic chemotherapy, or at second look laparotomy following chemotherapy. The response rates of these two groups to chemotherapy differ markedly, with patients who have relapsed following initial chemotherapy showing a reduction in response rates to subsequent chemotherapy. Analysis of these data show no statistically significant differences between the glutathione S-transferase activity or isoenzyme distribution in these two groups of patients. Significant differences were observed in the glutathione-S-transferase activities (GST) between tumours and normal ovaries. GST activities in pre-chemotherapy tumours (n = 33, P = 0.01) and post-chemotherapy tumours (n = 20, P = 0.001) where significantly higher than the GST activity in normal ovaries (n = 15). One feature was the expression of the basic isoenzyme which is expressed more in normal ovaries than in tumours. No differences in these parameters were observed in normal peritoneal tissue taken from patients before or after chemotherapy. These data do not support the hypothesis that changes in glutathione S-transferase enzyme activity or isoenzyme expression are major determinants of response to chemotherapy in ovarian tumours.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419640      PMCID: PMC1977974          DOI: 10.1038/bjc.1992.389

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Purification and characterization of a pi class glutathione S-transferase from human leukaemic cells.

Authors:  A Hall; S Foster; S J Proctor; A R Cattan
Journal:  Br J Haematol       Date:  1990-12       Impact factor: 6.998

2.  A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro.

Authors:  A T McGown; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

Authors:  W H Habig; M J Pabst; W B Jakoby
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

Review 4.  Gynecologic malignancies.

Authors:  J D Nash; R C Young
Journal:  Cancer Chemother Biol Response Modif       Date:  1988

5.  Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines.

Authors:  K Nakagawa; N Saijo; S Tsuchida; M Sakai; Y Tsunokawa; J Yokota; M Muramatsu; K Sato; M Terada; K D Tew
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

Review 6.  Chemotherapy of ovarian cancer.

Authors:  R F Ozols; R C Young
Journal:  Semin Oncol       Date:  1984-09       Impact factor: 4.929

7.  Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects.

Authors:  A D Lewis; J D Hayes; C R Wolf
Journal:  Carcinogenesis       Date:  1988-07       Impact factor: 4.944

8.  Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: an immunohistochemical study.

Authors:  B J Randall; B Angus; R Akiba; A Hall; A R Cattan; S J Proctor; R A Jones; C H Horne
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

9.  Determinants of drug response in a cisplatin-resistant human lung cancer cell line.

Authors:  Y Fujiwara; Y Sugimoto; K Kasahara; M Bungo; M Yamakido; K D Tew; N Saijo
Journal:  Jpn J Cancer Res       Date:  1990-05

10.  The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.

Authors:  P Mistry; L R Kelland; G Abel; S Sidhar; K R Harrap
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

View more
  9 in total

Review 1.  Overcoming drug resistance in ovarian carcinoma.

Authors:  P M Fracasso
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

Review 2.  Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies.

Authors:  Linjuan Xu; Jing Cai; Qiang Yang; Hui Ding; Liying Wu; Tao Li; Zehua Wang
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-18       Impact factor: 4.553

Review 3.  Human cell lines as models for multidrug resistance in solid tumours.

Authors:  M Clynes; M Heenan; K Hall
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 4.  Glutathione-related enzymes, glutathione and multidrug resistance.

Authors:  J A Moscow; K H Dixon
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

5.  Cisplatin nephrotoxicity: molecular mechanisms.

Authors:  Marie H Hanigan; Prasad Devarajan
Journal:  Cancer Ther       Date:  2003

6.  Expression of glutathione-S-transferases alpha and pi in gastric cancer: a correlation with cisplatin resistance.

Authors:  Y Kodera; K Isobe; M Yamauchi; K Kondo; S Akiyama; K Ito; I Nakashima; H Takagi
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patients.

Authors:  S Ghazal-Aswad; L Hogarth; A G Hall; M George; D P Sinha; M Lind; A H Calvert; J P Sunter; D R Newell
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

8.  Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases.

Authors:  W H Peters; H M Roelofs; W L van Putten; J B Jansen; J G Klijn; J A Foekens
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

9.  Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcome.

Authors:  E C Wrigley; A T McGown; H Buckley; A Hall; D Crowther
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.